“Recently the Economic Advisory council to PM said in a presentation to the stakeholder ministries like NITI Aayog and Department of Promotion of Industry and Internal Trade (DPIIT) for a slight change in the Indian patent working by suggesting recruitment…
After anti-influenza drug Tamiflu (Oseltamivir Phosphate) and antiretroviral drug Viread, Gilead Sciences is again back in news, this time with its hepatitis C (HCV) drug Sofosbuvir. Like Tamiflu and Viread's pre-grant opposition, Sofosbuvir patent application is also facing pre-grant opposition.…
Indian Patent Office (IPO) has recently published Draft Patents (Amendment) Rules 2013 and has invited comments (objections or suggestions) from the public within 45 days from the publication of the notification (12th June 2013). The main changes proposed are the…